Skip to content
10-Q

Quarterly Report

CORMEDIX INC. CRMD

0001213900-25-108777

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 10, 2025 78.79M sh
Shares Diluted Q3 2025 · Sep 30, 2025 86.21M sh
Shares Diluted Q3 2025 · Sep 30, 2025 75.68M sh
Shares Diluted Q3 2025 · Sep 30, 2024 58.83M sh
Shares Diluted Q3 2025 · Sep 30, 2024 57.99M sh
Capex Q3 2025 · Sep 30, 2025 $539.9K
Capex Q3 2025 · Sep 30, 2024 $105.86K
Operating Cash Flow Q3 2025 · Sep 30, 2025 $80.58M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$45M
Short Term Investments Q3 2025 · Sep 30, 2025 $7.22M
Short Term Investments Q3 2025 · Dec 31, 2024 $11.04M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $48.49M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $40.65M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $35.29M
Stockholders Equity Q3 2025 · Sep 30, 2025 $374.13M
Stockholders Equity Q3 2025 · Jun 30, 2025 $220.63M
Stockholders Equity Q3 2025 · Dec 31, 2024 $84.66M
Stockholders Equity Q3 2025 · Sep 30, 2024 $58.71M
Stockholders Equity Q3 2025 · Jun 30, 2024 $46.18M
Stockholders Equity Q3 2025 · Dec 31, 2023 $70.14M
Current Liabilities Q3 2025 · Sep 30, 2025 $133.64M
Current Liabilities Q3 2025 · Dec 31, 2024 $33.84M
Total Liabilities Q3 2025 · Sep 30, 2025 $376.73M
Total Liabilities Q3 2025 · Dec 31, 2024 $34.19M
Current Assets Q3 2025 · Sep 30, 2025 $259.54M
Current Assets Q3 2025 · Dec 31, 2024 $114.58M
Total Assets Q3 2025 · Sep 30, 2025 $750.86M
Total Assets Q3 2025 · Dec 31, 2024 $118.85M
Eps Diluted Q3 2025 · Sep 30, 2025 $1.26
Eps Diluted Q3 2025 · Sep 30, 2025 $1.97
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.05
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.54
Eps Basic Q3 2025 · Sep 30, 2025 $1.42
Eps Basic Q3 2025 · Sep 30, 2025 $2.12
Eps Basic Q3 2025 · Sep 30, 2024 −$0.05
Eps Basic Q3 2025 · Sep 30, 2024 −$0.54
Rd Expense Q3 2025 · Sep 30, 2025 $5.1M
Rd Expense Q3 2025 · Sep 30, 2025 $10.73M
Rd Expense Q3 2025 · Sep 30, 2024 $727.12K
Rd Expense Q3 2025 · Sep 30, 2024 $2.22M
Net Income Q3 2025 · Sep 30, 2025 $108.56M
Net Income Q3 2025 · Sep 30, 2025 $149.03M
Net Income Q3 2025 · Sep 30, 2024 −$2.78M
Net Income Q3 2025 · Sep 30, 2024 −$31.39M
Operating Income Q3 2025 · Sep 30, 2025 $51.35M
Operating Income Q3 2025 · Sep 30, 2025 $91.01M
Operating Income Q3 2025 · Sep 30, 2024 −$3.29M
Operating Income Q3 2025 · Sep 30, 2024 −$35.29M
Gross Profit Q3 2025 · Sep 30, 2025 $93.08M
Gross Profit Q3 2025 · Sep 30, 2025 $168.44M
Gross Profit Q3 2025 · Sep 30, 2024 $10.77M
Gross Profit Q3 2025 · Sep 30, 2024 $10.25M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $7.57M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $10.92M
Cost Of Revenue restated Q3 2025 · Sep 30, 2024 $634.65K
Cost Of Revenue restated Q3 2025 · Sep 30, 2024 $1.91M